What This Means for Practice In day-to-day practice, clinicians should discuss the potential mood-related effects of GLP1 drugs with realistic expectations
For example, in the lungs, GLP-1s may reduce the inflammatory response, improve oxidative stress, regulate protease/anti-protease imbalance, improve airway mucus homeostasis and reduce airway remodeling to provide benefit in patients with COPD
Yes, daily use helps maintain optimal levels and antioxidant protection
The problem is that most of the published evidence comes from animal studies, cell cultures, or research that only explains how a compound might work in theory not whether it actually produces results in real people
Learn how Novo prepared for launch and first-to-market dominance
Glucagon is released when blood glucose levels are low to stimulate the formation of new glucose in the liver and kidneys